Fructose Intestinal Gluconeogenesis
Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals With Obesity
Touro University, California
40 participants
Mar 2, 2026
INTERVENTIONAL
Conditions
Summary
This study will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. We will investigate whether this protective effect of the intestine is impaired in individuals with obesity.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Liquid meals containing 55% total carbohydrate (16% fructose), 30% fat, 15% protein.
55% total carbohydrate (6% fructose), 30% fat, 15% protein.
Tracer amount of 13C labeled fructose administered orally in the meals.
Tracer amount of 13C fructose administered intravenously
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07209202